Linked Life Data

15370365

Source:http://linkedlifedata.com/resource/pubmed/id/15370365

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-9-16
pubmed:abstractText
Collagen-crosslinking using combined riboflavin/ UVA treatment has been developed by us as a new treatment for keratoconus by stiffening the collagenous matrix. Recently, we have started to use the same method for the treatment of corneal ulcers. The aim of the present study was to evaluate the influence of the crosslinking treatment on the resistance of the cornea against enzymatic degradation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0271-3683
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
35-40
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Increased resistance of crosslinked cornea against enzymatic digestion.
pubmed:affiliation
Department of Ophthalmology, Universitätsklinikum CGC, Fetscherstrasse 74, D-01307 Dresden, Germany. eberhard.spoerl@uniklinikum-dresden.de
pubmed:publicationType
Journal Article